AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2017

Oct 4, 2017

35599_dirs_2017-10-04_6f857cc1-3f69-4e69-a699-691349c9a109.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11

Reporting Person: Essetifin SPA (10% Owner)
Reporting Person: Cavazza Enrico (10% Owner)
Reporting Person: Cavazza Silvia (10% Owner)
Reporting Person: Cavazza Francesca (10% Owner)
Reporting Person: Cavazza Preta Martina (10% Owner)
Reporting Person: CAVAZZA PAOLO (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2931579	Direct

Footnotes

F1: Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta, and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta, and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.